SKLB70326

Item number	Size	Delivery time	Price
TGM-T26194-25mg	25 mg	7 - 10 business days*	1,440.00€
TGM-T26194-50mg	50 mg	7 - 10 business days*	1,877.00€
TGM-T26194-100mg	100 mg	7 - 10 business days*	2,371.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: SKLB70326 is a cell-cycle progression inhibitor that acts by inducing G0/G1 phase... more

Close menu

Product information "SKLB70326"

Description: SKLB70326 is a cell-cycle progression inhibitor that acts by inducing G0/G1 phase arrest and apoptosis in human hepatic carcinoma cells. Target: Others. Smiles: NC=1C=2C(=NC(=CC2)C3=CC(OC)=CC=C3)SC1C(N)=O. References: Han Y, He H, Peng F, Liu J, Dai X, Lin H, Xu Y, Zhou T, Mao Y, Xie G, Yang S, Yu L, Yang L, Zhao Y. SKLB70326, a novel small-molecule inhibitor of cell-cycle progression, induces G0/G1 phase arrest and apoptosis in human hepatic carcinoma cells. Biochem Biophys Res Commun. 2012 May 18,421(4):684-9. doi: 10.1016/j.bbrc.2012.04.062. Epub 2012 Apr 21. PubMed PMID: 22542944.

Keywords:	SKLB-70326, SKLB 70326
Supplier:	TargetMol
Supplier-Nr:	T26194

Properties

MW:	299.35 D
Formula:	C15H13N3O2S

Database Information

CAS :

1257317-77-3| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "SKLB70326"

Write a review